MEDAPP S.A. ZY -10 (WQ1) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MEDAPP S.A. ZY -10 (WQ1) has a cash flow conversion efficiency ratio of 0.076x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.04 Million ≈ $2.39 Million USD) by net assets (€26.82 Million ≈ $31.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MEDAPP S.A. ZY -10 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how MEDAPP S.A. ZY -10's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MEDAPP S.A. ZY -10 (WQ1) total liabilities for a breakdown of total debt and financial obligations.
MEDAPP S.A. ZY -10 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEDAPP S.A. ZY -10 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aeris Environmental Ltd
AU:AEI
|
0.354x |
|
Sahakol Equipment Public Company Limited
BK:SQ
|
0.164x |
|
Home Pottery Public Company Limited
BK:HPT
|
0.010x |
|
Ho Wah Genting Bhd
KLSE:9601
|
0.211x |
|
DGB Group NV
AS:DGB
|
0.235x |
|
LCL Resources Ltd
AU:LCL
|
-0.033x |
|
Safello Group AB
ST:SFL
|
-0.015x |
|
YLI Holdings Bhd
KLSE:7014
|
-0.134x |
Annual Cash Flow Conversion Efficiency for MEDAPP S.A. ZY -10 (2021–2025)
The table below shows the annual cash flow conversion efficiency of MEDAPP S.A. ZY -10 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see MEDAPP S.A. ZY -10 (WQ1) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €26.82 Million ≈ $31.35 Million |
€2.44 Million ≈ $2.85 Million |
0.091x | -37.13% |
| 2024-12-31 | €28.84 Million ≈ $33.71 Million |
€4.17 Million ≈ $4.87 Million |
0.144x | +391.16% |
| 2023-12-31 | €26.73 Million ≈ $31.25 Million |
€-1.33 Million ≈ $-1.55 Million |
-0.050x | -123.57% |
| 2022-12-31 | €27.19 Million ≈ $31.79 Million |
€5.72 Million ≈ $6.69 Million |
0.210x | +1315.77% |
| 2021-12-31 | €25.25 Million ≈ $29.52 Million |
€-437.00K ≈ $-510.90K |
-0.017x | -- |
About MEDAPP S.A. ZY -10
MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D… Read more